Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.7974 |
Intermediate Similarity |
NPD7236 |
Approved |
0.7892 |
Intermediate Similarity |
NPD8470 |
Clinical (unspecified phase) |
0.7877 |
Intermediate Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.7834 |
Intermediate Similarity |
NPD7239 |
Suspended |
0.7831 |
Intermediate Similarity |
NPD7799 |
Discontinued |
0.7733 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7719 |
Intermediate Similarity |
NPD8407 |
Phase 2 |
0.7684 |
Intermediate Similarity |
NPD8485 |
Approved |
0.7647 |
Intermediate Similarity |
NPD8368 |
Discontinued |
0.7644 |
Intermediate Similarity |
NPD8361 |
Approved |
0.7644 |
Intermediate Similarity |
NPD8435 |
Approved |
0.7644 |
Intermediate Similarity |
NPD8360 |
Approved |
0.7635 |
Intermediate Similarity |
NPD7008 |
Discontinued |
0.7613 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7556 |
Intermediate Similarity |
NPD8486 |
Clinical (unspecified phase) |
0.753 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7529 |
Intermediate Similarity |
NPD8424 |
Clinical (unspecified phase) |
0.7471 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7457 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7457 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7429 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7394 |
Intermediate Similarity |
NPD7058 |
Phase 2 |
0.7394 |
Intermediate Similarity |
NPD7057 |
Phase 3 |
0.7389 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7389 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7375 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7368 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.736 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7351 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7346 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7345 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7315 |
Intermediate Similarity |
NPD6007 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD7961 |
Discontinued |
0.7292 |
Intermediate Similarity |
NPD7741 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7255 |
Intermediate Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.7254 |
Intermediate Similarity |
NPD2629 |
Approved |
0.7233 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7212 |
Intermediate Similarity |
NPD37 |
Approved |
0.7209 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7203 |
Intermediate Similarity |
NPD4198 |
Discontinued |
0.7197 |
Intermediate Similarity |
NPD7702 |
Clinical (unspecified phase) |
0.7192 |
Intermediate Similarity |
NPD5126 |
Approved |
0.7192 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.7186 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7186 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7186 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7186 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7133 |
Intermediate Similarity |
NPD5951 |
Approved |
0.7101 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7099 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7092 |
Intermediate Similarity |
NPD2181 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7075 |
Intermediate Similarity |
NPD7163 |
Clinical (unspecified phase) |
0.7066 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7059 |
Intermediate Similarity |
NPD7497 |
Discontinued |
0.7052 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7045 |
Intermediate Similarity |
NPD7240 |
Approved |
0.703 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6988 |
Remote Similarity |
NPD4380 |
Phase 2 |
0.6977 |
Remote Similarity |
NPD6232 |
Discontinued |
0.6973 |
Remote Similarity |
NPD7700 |
Phase 2 |
0.6973 |
Remote Similarity |
NPD7699 |
Phase 2 |
0.6964 |
Remote Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.6949 |
Remote Similarity |
NPD7685 |
Pre-registration |
0.6949 |
Remote Similarity |
NPD6559 |
Discontinued |
0.6941 |
Remote Similarity |
NPD7075 |
Discontinued |
0.6931 |
Remote Similarity |
NPD8320 |
Phase 1 |
0.6931 |
Remote Similarity |
NPD8319 |
Approved |
0.6928 |
Remote Similarity |
NPD6591 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD5402 |
Approved |
0.6919 |
Remote Similarity |
NPD7199 |
Phase 2 |
0.6918 |
Remote Similarity |
NPD5406 |
Approved |
0.6918 |
Remote Similarity |
NPD5405 |
Approved |
0.6918 |
Remote Similarity |
NPD5408 |
Approved |
0.6918 |
Remote Similarity |
NPD5404 |
Approved |
0.6914 |
Remote Similarity |
NPD7274 |
Clinical (unspecified phase) |
0.6913 |
Remote Similarity |
NPD7457 |
Clinical (unspecified phase) |
0.6909 |
Remote Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.6902 |
Remote Similarity |
NPD6534 |
Approved |
0.6902 |
Remote Similarity |
NPD6535 |
Approved |
0.6897 |
Remote Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.6897 |
Remote Similarity |
NPD6166 |
Phase 2 |
0.6897 |
Remote Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.6897 |
Remote Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.6894 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.689 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.6886 |
Remote Similarity |
NPD6599 |
Discontinued |
0.6878 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6875 |
Remote Similarity |
NPD7266 |
Discontinued |
0.6871 |
Remote Similarity |
NPD7610 |
Discontinued |
0.6864 |
Remote Similarity |
NPD5760 |
Phase 2 |
0.6864 |
Remote Similarity |
NPD5761 |
Phase 2 |
0.686 |
Remote Similarity |
NPD5494 |
Approved |
0.6859 |
Remote Similarity |
NPD7715 |
Approved |
0.6859 |
Remote Similarity |
NPD7714 |
Approved |
0.6856 |
Remote Similarity |
NPD8462 |
Phase 1 |
0.6852 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6846 |
Remote Similarity |
NPD3412 |
Clinical (unspecified phase) |
0.6845 |
Remote Similarity |
NPD7411 |
Suspended |
0.6842 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.6842 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.6831 |
Remote Similarity |
NPD6831 |
Clinical (unspecified phase) |
0.6831 |
Remote Similarity |
NPD2182 |
Approved |
0.6829 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6828 |
Remote Similarity |
NPD4869 |
Clinical (unspecified phase) |
0.6821 |
Remote Similarity |
NPD6959 |
Discontinued |
0.6807 |
Remote Similarity |
NPD5403 |
Approved |
0.6805 |
Remote Similarity |
NPD6801 |
Discontinued |
0.6792 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6788 |
Remote Similarity |
NPD8151 |
Discontinued |
0.6788 |
Remote Similarity |
NPD5401 |
Approved |
0.678 |
Remote Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.6772 |
Remote Similarity |
NPD6355 |
Discontinued |
0.677 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.676 |
Remote Similarity |
NPD6764 |
Approved |
0.676 |
Remote Similarity |
NPD6765 |
Approved |
0.6759 |
Remote Similarity |
NPD7094 |
Approved |
0.6759 |
Remote Similarity |
NPD6858 |
Approved |
0.6755 |
Remote Similarity |
NPD6287 |
Discontinued |
0.6753 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6753 |
Remote Similarity |
NPD7874 |
Approved |
0.6752 |
Remote Similarity |
NPD7713 |
Phase 3 |
0.6752 |
Remote Similarity |
NPD6663 |
Approved |
0.6752 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6748 |
Remote Similarity |
NPD3750 |
Approved |
0.6744 |
Remote Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.6743 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.6742 |
Remote Similarity |
NPD7074 |
Phase 3 |
0.6737 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6736 |
Remote Similarity |
NPD4141 |
Clinical (unspecified phase) |
0.6727 |
Remote Similarity |
NPD7390 |
Discontinued |
0.6726 |
Remote Similarity |
NPD3226 |
Approved |
0.6725 |
Remote Similarity |
NPD3817 |
Phase 2 |
0.6723 |
Remote Similarity |
NPD3818 |
Discontinued |
0.672 |
Remote Similarity |
NPD6779 |
Approved |
0.672 |
Remote Similarity |
NPD6780 |
Approved |
0.672 |
Remote Similarity |
NPD6776 |
Approved |
0.672 |
Remote Similarity |
NPD6777 |
Approved |
0.672 |
Remote Similarity |
NPD6782 |
Approved |
0.672 |
Remote Similarity |
NPD6778 |
Approved |
0.672 |
Remote Similarity |
NPD6781 |
Approved |
0.6717 |
Remote Similarity |
NPD8404 |
Phase 2 |
0.671 |
Remote Similarity |
NPD5736 |
Approved |
0.6708 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6702 |
Remote Similarity |
NPD7698 |
Approved |
0.6702 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6702 |
Remote Similarity |
NPD7697 |
Approved |
0.6688 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6687 |
Remote Similarity |
NPD8389 |
Clinical (unspecified phase) |
0.6687 |
Remote Similarity |
NPD2534 |
Approved |
0.6687 |
Remote Similarity |
NPD2532 |
Approved |
0.6687 |
Remote Similarity |
NPD2533 |
Approved |
0.6687 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6686 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6685 |
Remote Similarity |
NPD7054 |
Approved |
0.6667 |
Remote Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6667 |
Remote Similarity |
NPD230 |
Phase 1 |
0.6667 |
Remote Similarity |
NPD690 |
Clinical (unspecified phase) |
0.6649 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.6648 |
Remote Similarity |
NPD7472 |
Approved |
0.6647 |
Remote Similarity |
NPD3749 |
Approved |
0.6646 |
Remote Similarity |
NPD3748 |
Approved |
0.6633 |
Remote Similarity |
NPD7801 |
Approved |
0.663 |
Remote Similarity |
NPD7808 |
Phase 3 |
0.6629 |
Remote Similarity |
NPD3751 |
Discontinued |
0.6627 |
Remote Similarity |
NPD6799 |
Approved |
0.6624 |
Remote Similarity |
NPD7095 |
Approved |
0.6619 |
Remote Similarity |
NPD1238 |
Approved |
0.6619 |
Remote Similarity |
NPD7798 |
Approved |
0.6615 |
Remote Similarity |
NPD7680 |
Approved |
0.6612 |
Remote Similarity |
NPD6785 |
Approved |
0.6612 |
Remote Similarity |
NPD6784 |
Approved |
0.661 |
Remote Similarity |
NPD7997 |
Clinical (unspecified phase) |
0.6608 |
Remote Similarity |
NPD1934 |
Approved |
0.6605 |
Remote Similarity |
NPD2438 |
Suspended |
0.6596 |
Remote Similarity |
NPD1931 |
Clinical (unspecified phase) |
0.6596 |
Remote Similarity |
NPD1930 |
Approved |
0.6596 |
Remote Similarity |
NPD1929 |
Approved |
0.6591 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6584 |
Remote Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.6578 |
Remote Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.6578 |
Remote Similarity |
NPD6213 |
Phase 3 |
0.6578 |
Remote Similarity |
NPD6212 |
Phase 3 |
0.6575 |
Remote Similarity |
NPD7251 |
Discontinued |
0.657 |
Remote Similarity |
NPD1465 |
Phase 2 |
0.6564 |
Remote Similarity |
NPD5762 |
Approved |
0.6564 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6564 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6564 |
Remote Similarity |
NPD5763 |
Approved |
0.6564 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.6564 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.6564 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.6554 |
Remote Similarity |
NPD8051 |
Clinical (unspecified phase) |
0.6549 |
Remote Similarity |
NPD164 |
Approved |
0.6548 |
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.6548
|
Remote Similarity |
NPD7314 |
Clinical (unspecified phase) |